[Télédent, an oral tele-expertise experience in a penitentiary environment]. / Télédent, une expérience de téléexpertise bucco-dentaire en milieu pénitentiaire.

The oral health has an important role in the good general health state. Some populations, including those in detention, have not only increased needs, but also limited access to dental care. Télédent is an oral tele-expertise activity that facilitates the screening and prevention of oral disorders, performing as a complementary health tool for screening. With an intra-oral camera, oral images of the prisoners are recorded and then analyzed by a team from the Oral Medicine Department of the Hospital Henri Mondor, giving the UCSA of Fresnes prison a detailed dental expertise. As a result, Télédent enables a cooperation to improve the screening and oral care of prison inmates at the Fresnes Prison, decreasing costs and increasing the security.

TITLE: Télédent, une expérience de téléexpertise bucco-dentaire en milieu pénitentiaire. ABSTRACT: La santé bucco-dentaire participe au maintien d'un bon état général de l'organisme. Certaines populations, dont les personnes détenues, ont des besoins importants mais, simultanément, un accès limité aux soins dentaires. Télédent est un outil complémentaire de téléexpertise bucco-dentaire qui facilite le dépistage et la prévention des troubles oraux. À partir d'une caméra intra-buccale qui enregistre des images qui sont analysées par l'équipe du service de médecine bucco-dentaire de l'Hôpital Henri Mondor, l'Unité sanitaire du centre pénitentiaire de Fresnes dispose d'une expertise dentaire détaillée. Télédent permet ainsi une coopération entre les services qui améliore le dépistage et la prise en charge de soins bucco-dentaires, tout en diminuant les coûts et en favorisant la sécurité des patients détenus.

Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates.

BACKGROUND: Prison inmates are considered a high-risk population for blood-borne and enterically transmitted infections before and during their imprisonment. Hepatitis E virus (HEV) prevalence is unknown among French inmates, whereas a reassessment of human immunodeficiency virus (HIV), hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) prevalences is required to describe the epidemiologic evolution in this high-risk population. METHODS: A prospective survey was conducted from June to December 2017 in Fresnes prison, a penitentiary center with 2,581 inmates. In addition to HIV, HAV, HBV and HCV testing, which is offered to all patients at admission, we systematically offered HEV screening. Retrospective serological data for HIV, HBV and HCV, collected annually from 2014 to 2017, were also used to assess evolution. RESULTS: In 2017, 1,093 inmates were screened for HEV, HIV, HAV, HBV and HCV. Prevalences in this population were 8.2%, 1.3%, 62.7%, 1.9% and 2.9%, respectively. HEV seroprevalence increased with age (p<0.0001) and was higher among Eastern Europe born inmates (p<0.0001). Between 2014 and 2017, HIV seroprevalence remained steady, while a decrease in HBV and HCV seroprevalence was observed. CONCLUSIONS: Compared to the reported prevalence in French blood donors, HEV seroprevalence was remarkably low in French inmates. HIV, HAV, HBV and HCV prevalences among prisoners were higher than reported in the general population.